Skin Disease Treatment Technologies and Global Markets

Published - Jan 2016| Analyst - Paul Evers| Code - PHM127B
Skin Disease Treatment Technologies and Global Markets
Single User License: $2,750 Member Price: FREE

Report Highlights

The global market for skin disease treatment technologies reached $16.4 billion in 2014 and $17.1 billion in 2015. The market should reach $20.4 billion in 2020, demonstrating a compound annual growth rate (CAGR) of 3.6% from 2015 to 2020.

Report Includes

  • An overview of the global market for treatments of skin diseases, perhaps the most common of human afflications.
  • Analyses of global market trends, with data from 2014, 2015, and projections of compound annual growth rates (CAGRs) through 2020.
  • Focused coverage of four major categories of skin disease of exceptional medical and commercial significance: dermatitis (allergic and contact), cancers (including melanoma), immune disorders (including psoriasis), and infections (bacterial, fungal and viral).
  • Topics such as skin structure and function, diseases of the skin, current treatment options, and unmet clinical needs.
  • Discussion of the evolution of the market, including the rising prevalence of some skin diseases, and new diagnostic and treatment options.
  • Examination of the global market by product categories, such as anti-allergic products, antibacterials, antifungals, antivirals, immunotherapies, and anticancers.
  • Profiles of major players in the industry.

SCOPE OF REPORT

This report discusses the implications of the above-mentioned trends in the context of the current size and growth of the dermatology market, discussed both in global terms and in reference to the most important national markets. Long-standing and emerging companies are discussed, with profiles of their leadership and an update on M&A activity. Five-year global sales forecasts are provided for main drug categories, and breakdowns are provided for several national markets.

ANALYST'S CREDENTIALS

Paul Evers has been involved in analyzing pharmaceutical and medical markets for 20 years. He is the author of several previous BCC Research reports on diseases affecting different organ systems in addition to the skin.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Note: Reports are discounted or included with certain Memberships. See Membership Options.
 
Published - May-2013| Analyst - Paul Evers| Code - PHM127A

Report Highlights

The global dermatology markets reached $15.8 billion in 2012. The market is expected to reach $16.1 billion in 2013 and $18.5 billion in 2018 for a CAGR of 2.8%.

Report Includes

  • An overview of the global market for treatments of skin diseases, perhaps the most common of human afflications
  • Analyses of global market trends, with data from 2011 and 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018
  • Focused coverage of four major categories of skin disease of exceptional medical and commercial significance: dermatitis (allergic and contact), cancers (including melanoma), immune disorders (including psoriasis), and infections (bacterial, fungal and viral)
  • Topics such as skin structure and function, diseases of the skin, current treatment options, and unmet clinical needs
  • Discussion of the evolution of the market, including the rising prevalence of some skin diseases, and new diagnostic and treatment options
  • Examination of the global market by product categories, such as anti-allergic products, antibacterials, antifungals, antivirals, immunotherapies, and anticancers
  • Comprehensive company profiles of major players.

Want to Customize this Report?

Contact us for a confidential discussion.

781-205-2433

Custom Report
RELATED REPORTS
Share This Report